Table 2.
Demographic Characteristics
| Parameter | Values | |
|---|---|---|
| Age (years) (n=159) | Median (range) | 48 (19–67) |
| > 40 | N (%) | 126 (79%) |
| ≤ 40 | 33 (21%) | |
| Gender, N (%) (n=159) | Male | 99 (62 %) |
| Female | 60 (38 %) | |
| Infection Status, N (%) (n=159) | HCV infected | 58 (36%) |
| HCV/HIV co-infected | 77 (48%) | |
| HCV/HBV co-infected | 1 (1%) | |
| HCV/HIV/HBV co-infected | 5 (3%) | |
| HIV infected | 2 (1%) | |
| HIV/HBV infected | 7 (4%) | |
| HBV infected | 2 (1%) | |
| No Infection | 7 (4%) | |
| HCV antibody, N (%) (n=159) | Positive | 141 (89 %) |
| Negative | 17 (11%) | |
| Not determined | 1 (1 %) | |
| HCV RNA (IU/ml) | Median | 1,575,518 |
| ≤ 1,000,000 | N (%) (n=141) | 62 (44%) |
| >1,000,000 | 76 (54%) | |
| Not determined | 3 (2%) | |
| HCV Genotype 1 | N (%) (n=141) | 112 (79%) |
| Non-1 | 16 (11%) | |
| Not determined | 13 (9%) | |
| HIV Positive, N (%) (n=159) | Positive | 91 (57%) |
| Negative | 68 (43%) | |
| HIV RNA, N (%) (n=91) | Detectable | 39 (43%) |
| Undetectable | 51 (56%) | |
| Not Found | 1 (1%) | |
| CD4+ (cells/ml) (n=92) | Median (range) | 457 (24–1092) |
| ≤ 200 | N (%) (n=92) | 14 (15%) |
| 200–500 | 43 (47%) | |
| ≥ 500 | 35 (38%) | |
| HBsAg, N (%)(n=159) | Positive | 15 (9%) |
| Negative | 129 (81%) | |
| Undetermined | 15 (9%) | |
| Hepatic Fibrosis Stagea N (%) (n=159) | Advanced (≥ 2) | 93 (58%) |
| Mild (< 2) | 30 (19%) | |
| None (0) | 3 (2%) | |
| Not determined | 33 (21%) | |
| Inflammatory Gradea N (%) (n=159) | Severe (≥ 2) | 84 (53%) |
| Mild (< 2) | 31 (19%) | |
| Not determined | 44 (28%) | |
a
Stage and grade assessed using the Scheuer system [23]
Abbreviations: HCV, hepatitis C virus; HBV, hepatitis B virus; HBsAg, hepatitis B virus surface antigen; HIV, human immunodeficiency virus; IU, international units.